š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
The main objectives of this study are to compare the first and second recov...
Status
Completed
Location
Klinika Haematologii, Akademia Medyczna w Bialymstokiu, ul.
Start Date
2001-09
Trial ID
NCT02246868
Treatments Being Tested
The main objective of the study is to assess the pharmacokinetics of OPTIVA...
Status
Terminated
Location
Rambam Health Care Campus, 8 Haaliya St., Bat-Galim
Start Date
2006-11
Trial ID
NCT00387192
Treatments Being Tested
The main objective of the study is to investigate the safety and efficacy o...
Status
Completed
Location
Klinika Haematologii, Akademia Medyczna w Gdansku, ul.
Start Date
2001-11
Trial ID
NCT02250482
Treatments Being Tested
The purpose of this study is to evaluate whether a concentrate containing b...
Status
Completed
Location
City of Hope Medical Center
Start Date
2009-11-03
Trial ID
NCT01051076
Treatments Being Tested
An open, multi-centre study in patients with von Willebrand Disease (VWD) u...
Status
Terminated
Location
Rambam Health Care Campus, 8 Haaliya St., Bat-Galim
Start Date
2007-02
Trial ID
NCT00404300
Treatments Being Tested
The main objectives of the study were * to compare the pharmacokinetics (P...
Status
Completed
Location
Hematology Dept., Sackler School of Medicine, Tel Aviv University
Start Date
2004-12
Trial ID
NCT02250508
Treatments Being Tested
Primary objective: To assess post-marketing immunogenicity of OptivateĀ® by ...
Status
Terminated
Location
Fundacion BIOS
Start Date
2014-11-21
Trial ID
NCT01811875
Treatments Being Tested
This is a prospective, controlled, randomized, open label study, aimed at c...
Status
Withdrawn
Location
Multiple Locations
Start Date
2009-09-25
Trial ID
NCT01051544
Treatments Being Tested
The main objectives of this study are: * to assess OptivateĀ® consumption (...
Status
Completed
Location
Children's Haematology and Oncology Clinic, Ul.
Start Date
2003-11
Trial ID
NCT02246894
Treatments Being Tested
The main objective of the study is to compare the pharmacokinetics of Optiv...
Status
Completed
Location
Klinika Haematologii, Akademia Medyczna w Gdansku, ul.
Start Date
2001-10
Trial ID
NCT02246881
Treatments Being Tested